checkAd
    Startseite > Aktien > Coya Therapeutics > Nachrichten
    Coya Therapeutics Aktie
    8,3000
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 17:15:17 Nasdaq
    8,2800
     
    USD
    100 STK
    Geldkurs 18:11:02
    8,4900
     
    USD
    100 STK
    Briefkurs 18:11:02
    ISIN: US22407B1089 · WKN: A3DZRY · SYM: COYA · USA

    Neueste Nachrichten

    Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease
    14:15 Uhr · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)
    20.05.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
    09.05.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
    26.04.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics to Participate in the Mizuho Neuroscience Summit
    22.04.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
    18.04.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
    08.04.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
    19.03.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics to Participate in BTIG Fireside Discussion
    12.03.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Presents ALS Biomarker Data at Society of Neuroimmune Pharmacology Conference
    12.03.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia (FTD) at the AD/PD 2024 Conference
    06.03.24 · Business Wire (engl.) · Coya Therapeutics
    Coya Therapeutics to Present Data on Immune System and Regulatory T Cell (Treg) Contributions in Frontotemporal Dementia (FTD) Patients at AD/PD 2024 Conference
    29.02.24 · Business Wire (engl.) · Coya Therapeutics